Please wait...
About This Project
Therapeutics in any modality to combat Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections are in urgent demand across the entire world as the Coronavirus Disease 2019 (COVID-19) pandemic continues to interrupt the well-being of human life. Without clinical therapeutics available for any of the human coronaviruses, a key starting point is to focus on target-based high-throughput screening (HTS) to reveal potent anti-SARS-CoV-2 hit-to-leads that are safe to human cells.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Open Insulin
A team of biohackers is developing the first open source protocol to produce insulin simply and economically...
Can we use our immune cells to fight lung disease?
Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...
Can immune cells prevent 3D printed blood vessels from falling apart?
Mass production of cells is limited by nutrient delivery. 3D printing of hydrogel has enabled the printing...